COMPANY
ACCORD HEALTHCARE LIMITED
ACCORD HEALTHCARE LIMITED: marketing authorisation holder for Daptomycin, Degarelix, Desmopressin, Icatibant, Leuprolide, Teriparatide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Daptomycin | DAPTOMYCIN 350 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 20075/1171, Authorised Regulator MHRA |
|---|---|
| Daptomycin | DAPTOMYCIN 350 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 20075/1386, Authorised Regulator MHRA |
| Daptomycin | DAPTOMYCIN 500 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 20075/1172, Authorised Regulator MHRA |
| Daptomycin | DAPTOMYCIN 500 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 20075/1387, Authorised Regulator MHRA |
| Degarelix | DEGARELIX 120 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, PLGB 20075/1486, Authorised Regulator MHRA |
| Degarelix | DEGARELIX 80 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, PLGB 20075/1485, Authorised Regulator MHRA |
| Desmopressin | DESMOPRESSIN NASAL SPRAY 10 MICROGRAMS/DOSE, PL 20075/0571, Authorised Regulator MHRA |
| Icatibant | ICATIBANT ACCORD 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PLGB 20075/1455, Authorised Regulator MHRA |
| Leuprolide | CAMCEVI 21MG PROLONGED-RELEASE SUSPENSION FOR INJECTION, PL 20075/1580, Authorised Regulator MHRA |
| Leuprolide | CAMCEVI 42 MG PROLONGED-RELEASE SUSPENSION FOR INJECTION, PLGB 20075/1528, Authorised Regulator MHRA |
| Teriparatide | SONDELBAY, PLGB 20075/1471, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.